KMB — Kimberly-Clark Corporation

Is KMB overbought or oversold? Here is the current MarketMoodz read.

Consumer Defensive · Household & Personal Products

Neutral As of November 17, 2026

Kimberly-Clark Corporation (KMB) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Consumer Defensive name (Household & Personal Products) last closed at $111.34. The rating moved from Oversold to Neutral on November 14, 2026.

AI analysis

Kimberly-Clark Corporation (KMB) benefits from durable, branded consumer products with predictable cash flows and a defensive profile that is attractive during rotation into staples. Recent market tone favors low-volatility names, supporting near-term stability. Key positives include strong household brands, steady dividend cash flow, and ongoing productivity programs that can protect margins as input costs moderate. Risks include commodity and freight cost volatility, private-label competition, and potential weakness in consumer spending. Overall outlook is for steady cash generation with modest upside from pricing and cost actions, while execution and macro sensitivity remain the primary watch points.

Key factors

  • Kimberly-Clark Corporation (KMB) has a portfolio of strong, household consumer brands (Kleenex, Huggies, Kotex) that support stable demand and pricing power in defensive categories.
  • Portfolio cash flow and a historically reliable dividend profile make the company attractive during risk-off or rotation into staples.
  • Ongoing cost-management and productivity programs can help protect margins as commodity and freight pressures normalize.
  • Current market tone shows rotation into consumer staples and defensive ETFs, providing tailwinds for KMB relative to cyclicals.
  • Relatively low beta and predictable revenue streams reduce short-term volatility versus broader market swings.
  • Opportunities for incremental pricing and innovation in babycare and tissue segments support modest revenue growth and margin recovery.

Risks

  • Sustained or renewed raw material (pulp, resin) and freight inflation that compresses margins if not fully passed through to consumers.
  • Private-label competition and price-sensitive consumers could limit pricing power and volume recovery in certain markets.
  • Slower consumer spending or recessionary pressure could reduce demand for discretionary hygiene and tissue upgrades.
  • Foreign exchange exposure and international market weakness could erode reported results and cash flow.
  • Execution risk on cost-savings programs and integration of any acquisitions could delay expected benefits.
  • Sentiment or liquidity shocks that prompt dividend scrutiny or capital allocation trade-offs could depress valuation.

Latest MarketMoodz coverage

See today's live rating, score and targets

Members see the live hourly rating for KMB — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.